{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:01:52Z","timestamp":1740146512064,"version":"3.37.3"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T00:00:00Z","timestamp":1555632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0215079","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T17:32:23Z","timestamp":1555695143000},"page":"e0215079","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of HIV-exposure and timing of anti-retroviral treatment on immunogenicity of trivalent live-attenuated polio vaccine in infants"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8490-8977","authenticated-orcid":true,"given":"Shelina","family":"Moonsamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda","family":"Suchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabir A.","family":"Madhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,4,19]]},"reference":[{"issue":"43","key":"ref1","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1016\/j.vaccine.2016.05.062","article-title":"Contribution of polio eradication initiative to strengthening routine immunization: Lessons learnt in the WHO African region","volume":"34","author":"BM Anya","year":"2016","journal-title":"Vaccine"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2217\/fmb.15.19","article-title":"Polio vaccination: past, present and future","volume":"10","author":"AS Bandyopadhyay","year":"2015","journal-title":"Future Microbiol"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/21645515.2015.1088617","article-title":"Polio elimination in Nigeria: A review","volume":"12","author":"UN Nasir","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"010701","DOI":"10.7189\/jogh.07.010701","article-title":"Toward elimination of mother-to-child transmission of HIV in South Africa: how best to monitor early infant infections within the Prevention of Mother-to-Child Transmission Program","volume":"7","author":"GG Sherman","year":"2017","journal-title":"J Glob Health"},{"key":"ref5","unstructured":"South African Medical Research Council. Early mother-to-child transmission of HIV stats plunge 2016 [<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.mrc.ac.za\/media-release\/early-mother-child-transmission-hiv-stats-plunge\" xlink:type=\"simple\">http:\/\/www.mrc.ac.za\/media-release\/early-mother-child-transmission-hiv-stats-plunge<\/ext-link>."},{"issue":"3 Suppl 1","key":"ref6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7196\/SAMJ.7605","article-title":"Elimination of mother-to-child transmission of HIV in South Africa: rapid scale-up using quality improvement","volume":"104","author":"S Bhardwaj","year":"2014","journal-title":"S Afr Med J"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cei.12251","article-title":"HIV-exposed uninfected children: a growing population with a vulnerable immune system?","volume":"176","author":"L Afran","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3389\/fimmu.2017.01060","article-title":"Editorial: Immune Mechanisms Underlying the Increased Morbidity and Mortality of HIV-Exposed Uninfected (HEU) Children","volume":"8","author":"T Goetghebuer","year":"2017","journal-title":"Front Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fimmu.2016.00383","article-title":"The Immune System of HIV-Exposed Uninfected Infants","volume":"7","author":"B Abu-Raya","year":"2016","journal-title":"Front Immunol"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"e0151762","DOI":"10.1371\/journal.pone.0151762","article-title":"Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration","volume":"11","author":"E Morden","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"ref11","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/cid\/cit937","article-title":"Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis","volume":"58","author":"S Kerneis","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/infdis\/jiu841","article-title":"Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults","volume":"211","author":"SB Troy","year":"2015","journal-title":"J Infect Dis"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/QAD.0b013e32835fae26","article-title":"Effect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine","volume":"27","author":"OE Simani","year":"2013","journal-title":"AIDS"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"e1260","DOI":"10.1371\/journal.pone.0001260","article-title":"HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization","volume":"2","author":"MC Tejiokem","year":"2007","journal-title":"PLoS One"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nrmicro1550","article-title":"Global measles elimination","volume":"4","author":"WJ Moss","year":"2006","journal-title":"Nat Rev Microbiol"},{"issue":"Suppl 1","key":"ref16","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1093\/infdis\/jir071","article-title":"Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity","volume":"204","author":"P Scott","year":"2011","journal-title":"J Infect Dis"},{"issue":"21","key":"ref17","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants","volume":"359","author":"A Violari","year":"2008","journal-title":"N Engl J Med"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1086\/657401","article-title":"Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort study","volume":"51","author":"IJ Collins","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/165.3.553","article-title":"Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine","volume":"165","author":"MC Rodriguez-Barradas","year":"1992","journal-title":"J Infect Dis"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1086\/653704","article-title":"Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants","volume":"202","author":"SA Madhi","year":"2010","journal-title":"J Infect Dis"},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1258\/ijsa.2009.009126","article-title":"Hepatitis B vaccination in HIV-infected adults: current evidence, recommendations and practical considerations","volume":"20","author":"HN Kim","year":"2009","journal-title":"Int J STD AIDS"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.4161\/hv.21827","article-title":"Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions","volume":"8","author":"A Cagigi","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"5 Pt 1","key":"ref23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0022-3476(06)80007-7","article-title":"Safety and immunogenicity of bacille Calmette-Guerin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1","volume":"122","author":"RW Ryder","year":"1993","journal-title":"J Pediatr"},{"issue":"14","key":"ref24","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.vaccine.2005.12.021","article-title":"Serological response to pneumococcal vaccination in HAART-treated HIV-infected patients: one year follow-up study","volume":"24","author":"V Falco","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1080\/21645515.2017.1359454","article-title":"Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants","volume":"13","author":"JA Church","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"16","key":"ref26","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.vaccine.2013.02.044","article-title":"Reduced Poliovirus vaccine neutralising-antibody titres in infants with maternal HIV-exposure","volume":"31","author":"M Sanz-Ramos","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/infdis\/jit208","article-title":"Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants","volume":"208","author":"SB Troy","year":"2013","journal-title":"J Infect Dis"},{"key":"ref28","unstructured":"Expanded Programme on Immunisation. New EPI Vaccines Guidelines: The National Department of Health, Republic of South Africa, 2009 [updated October 2010. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.health-e.org.za\/wp-content\/uploads\/2014\/02\/South-Africa-EPI-vaccines-revised-Oct-2010.pdf\" xlink:type=\"simple\">https:\/\/www.health-e.org.za\/wp-content\/uploads\/2014\/02\/South-Africa-EPI-vaccines-revised-Oct-2010.pdf<\/ext-link>."},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot087379","article-title":"Crystal Violet Assay for Determining Viability of Cultured Cells","volume":"2016","author":"M Feoktistova","year":"2016","journal-title":"Cold Spring Harb Protoc"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","article-title":"Determination of 50% endpoint titer using a simple formula","volume":"5","author":"MA Ramakrishnan","year":"2016","journal-title":"World J Virol"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"e1002140","DOI":"10.1371\/journal.pmed.1002140","article-title":"Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data","volume":"13","author":"M Pons-Salort","year":"2016","journal-title":"PLoS Med"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1469-0691.2004.00998.x","article-title":"A seroprevalence study of poliovirus antibody in the population of northern Greece","volume":"11","author":"F Frantzidou","year":"2005","journal-title":"Clin Microbiol Infect"},{"issue":"35","key":"ref33","doi-asserted-by":"crossref","first-page":"12889","DOI":"10.1073\/pnas.1323502111","article-title":"Robustness against serum neutralization of a poliovirus type 1 from a lethal epidemic of poliomyelitis in the Republic of Congo in 2010","volume":"111","author":"JF Drexler","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref34","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1086\/520546","article-title":"Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants","volume":"196","author":"EJ Asturias","year":"2007","journal-title":"J Infect Dis"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/605331","article-title":"Polio: measuring the protection that matters most","volume":"200","author":"PE Fine","year":"2009","journal-title":"J Infect Dis"},{"issue":"11","key":"ref36","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/CVI.05225-11","article-title":"Development of a poliovirus neutralization test with poliovirus pseudovirus for measurement of neutralizing antibody titer in human serum","volume":"18","author":"M Arita","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity","volume":"47","author":"SA Plotkin","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"suppl_1","key":"ref38","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/infdis\/jix117","article-title":"Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future","volume":"216","author":"M Patel","year":"2017","journal-title":"J Infect Dis"},{"issue":"suppl_1","key":"ref39","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1093\/infdis\/jiw626","article-title":"Implementing the Synchronized Global Switch from Trivalent to Bivalent Oral Polio Vaccines-Lessons Learned From the Global Perspective","volume":"216","author":"A Ramirez Gonzalez","year":"2017","journal-title":"J Infect Dis"},{"issue":"40","key":"ref40","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1016\/j.vaccine.2008.03.062","article-title":"Delayed early antiretroviral treatment is associated with an HIV-specific long-term cellular response in HIV-1 vertically infected infants","volume":"26","author":"P Palma","year":"2008","journal-title":"Vaccine"},{"issue":"19","key":"ref41","doi-asserted-by":"crossref","first-page":"7939","DOI":"10.1073\/pnas.0901702106","article-title":"Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children","volume":"106","author":"S Pensieroso","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"16","key":"ref42","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1097\/00002030-200111090-00002","article-title":"Kinetics of the T-cell receptor CD4 and CD8 V beta repertoire in HIV-1 vertically infected infants early treated with HAART","volume":"15","author":"ML Romiti","year":"2001","journal-title":"AIDS"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/infdis\/173.5.1077","article-title":"Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection","volume":"173","author":"MI de Moraes-Pinto","year":"1996","journal-title":"J Infect Dis"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"F202","DOI":"10.1136\/fn.79.3.F202","article-title":"Placental antibody transfer: influence of maternal HIV infection and placental malaria","volume":"79","author":"MI de Moraes-Pinto","year":"1998","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2 Suppl","key":"ref45","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1590\/0001-3765201520140663","article-title":"The re-emergency and persistence of vaccine preventable diseases","volume":"87","author":"RC Borba","year":"2015","journal-title":"An Acad Bras Cienc"},{"issue":"52","key":"ref46","doi-asserted-by":"crossref","first-page":"6707","DOI":"10.1016\/j.vaccine.2016.10.025","article-title":"Vaccine impact: Benefits for human health","volume":"34","author":"M Doherty","year":"2016","journal-title":"Vaccine"},{"issue":"52","key":"ref47","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1016\/j.vaccine.2016.11.014","article-title":"The changing face of vaccines and vaccination","volume":"34","author":"PL Stern","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"ref48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1586\/14760584.4.2.167","article-title":"ELISA as a possible alternative to the neutralization test for evaluating the immune response to poliovirus vaccines","volume":"4","author":"AP Ivanov","year":"2005","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/ije\/19.1.164","article-title":"How to predict the immune status of poliovirus vaccinees? A comparison of virus neutralization at a very low serum dilution versus ELISA in a cohort of infants","volume":"19","author":"A Simhon","year":"1990","journal-title":"Int J Epidemiol"},{"issue":"Suppl 3","key":"ref50","doi-asserted-by":"crossref","first-page":"C35","DOI":"10.1016\/j.vaccine.2012.02.056","article-title":"Introduction of inactivated polio vaccine (IPV) into the routine immunization schedule of South Africa","volume":"30","author":"BD Schoub","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"ref51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/14656566.2017.1363180","article-title":"Developments in early diagnosis and therapy of HIV infection in newborns","volume":"19","author":"F Canals","year":"2018","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"ref52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/tropej\/fmu044","article-title":"Overcoming the barriers to timely antiretroviral initiation in HIV-infected infants","volume":"60","author":"A Sturt","year":"2014","journal-title":"J Trop Pediatr"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0215079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T09:27:41Z","timestamp":1589016461000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0215079"}},"subtitle":[],"editor":[{"given":"Heather B","family":"Jaspan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,4,19]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0215079","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2019,4,19]]}}}